Skip to content

Study of effect of herbal serum in skin glow

A comparative controlled clinical pilot study to evaluate skin brightening and rejuvenating activity of serum - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058229
Enrollment
45
Registered
2023-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L818- Other specified disorders of pigmentation

Interventions

Intervention1: Skin Brightening and Rejuvenating serum: 0.5 ml serum applied on the once in a day after bath for 30 days Control Intervention1: Rose Hip Brightening Glow Face Serum: 0.5 ml applied on

Sponsors

Yadnya Mahendra Gite
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Subjects with skin type III to VI. 2)Subject with blemishes and pigments present on the skin. 3)Subjects those not willing to apply any other cosmetic for Skin Brightening

Exclusion criteria

Exclusion criteria: 1)Age above 45 Yrs and below 18 Yrs. 2) Subjects who are taking Topical or Systemic Antihistaminic drug. 3) Subjects with abnormality on a face including wound, scar, erythema and Acne. 4) Smokers, alcohol addicted, caffeine addicted Subjects. 5) Subjects having Malignancy or any previous history of cosmetic Surgery. 6) Major illness regarding skin like facial psoriasis, eczema, tinea corporis etc

Design outcomes

Primary

MeasureTime frame
Improvement in melanin content on topical applicationTimepoint: 30 days.

Secondary

MeasureTime frame
To study post treatment brightening & rejuvenating effect of serum up to 30 daysTimepoint: 30 Days

Countries

India

Contacts

Public ContactYadnya Mahendra Gite

Ayurved Seva Sangh Ayurved Mahavidyalaya Ganeshwadi, Panchavati Nashik

sanjivanirathod431@gmail.com8007229141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026